Rubicon Research’s IPO, backed by Arihant Capital with a “Subscribe” rating, highlights the company’s strong growth and diversified pharma portfolio. The US-focused generics and specialty drug player has seen revenue jump to Rs 12,962 crore in FY25 and net profit rebound to Rs 1,344 crore. The IPO is fairly valued, aiming to attract both institutional...Read More
Waaree Renewable Technologies shares: It reported a more than twofold jump in consolidated net profit to Rs 116.34 crore in Q2 FY25 from Rs 53.51 crore a year earlier, driven by record revenues and strong project execution. The company attributed the performance to sectoral tailwinds and its expansion into new energy segments such as battery...Read More
Gold prices have surged to an all-time high. This rise is fueled by renewed trade tensions between the US and China. Investors are seeking safe havens amid global economic and political uncertainties. Expectations of further interest rate cuts by the US Federal Reserve are also supporting gold’s upward trend.Read More
The company has fixed Tuesday as the record date to determine shareholders eligible for the stock split in the ratio of 1:10. Under the split, each existing equity share of face value Rs 10 will be subdivided into 10 equity shares of face value Re 1 each, fully paid up.Read More
Nulla vitae elit libero, a pharetra augue. Nulla vitae elit libero, a pharetra augue. Nulla vitae elit libero, a pharetra augue. Donec sed odio dui. Etiam porta sem malesuada.
